Role of Wnt5a in suppressing invasiveness of hepatocellular carcinoma via epithelial-mesenchymal transition.
暂无分享,去创建一个
K. Wakayama | H. Kamachi | N. Kobayashi | T. Kamiyama | H. Yokoo | A. Taketomi | Shingo Shimada | T. Orimo | A. Nagatsu | T. Mitsuhashi | M. Fukai | K. Wakizaka
[1] Hai-Yan Min,et al. Regulation of Proliferation and Epithelial-to-Mesenchymal Transition (EMT) of Gastric Cancer by ZEB1 via Modulating Wnt5a and Related Mechanisms , 2019, Medical science monitor : international medical journal of experimental and clinical research.
[2] P. Schirmacher,et al. EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma. , 2018, Journal of hepatology.
[3] S. Adams,et al. Matrix Metalloproteinase Inhibitors in Cancer Therapy: Turning Past Failures Into Future Successes , 2018, Molecular Cancer Therapeutics.
[4] Li Zhu,et al. Wnt5a promotes epithelial-to-mesenchymal transition and metastasis in non-small-cell lung cancer , 2017, Bioscience reports.
[5] T. Andersson,et al. Higher expression of WNT5A protein in oral squamous cell carcinoma compared with dysplasia and oral mucosa with a normal appearance , 2017, European journal of oral sciences.
[6] R. Nusse,et al. Wnt/β-Catenin Signaling, Disease, and Emerging Therapeutic Modalities , 2017, Cell.
[7] T. Kipps,et al. Wnt5a Signaling in Normal and Cancer Stem Cells , 2017, Stem cells international.
[8] T. Andersson,et al. WNT5A signaling impairs breast cancer cell migration and invasion via mechanisms independent of the epithelial-mesenchymal transition , 2016, Journal of experimental & clinical cancer research : CR.
[9] M. Stack,et al. Wnt5a Signaling in Cancer , 2016, Cancers.
[10] Zhenbin Zhong,et al. Decreased Wnt5a Expression is a Poor Prognostic Factor in Triple-Negative Breast Cancer , 2016, Medical science monitor : international medical journal of experimental and clinical research.
[11] Y. Suh,et al. Wnt5a, Ryk and Ror2 expression in glioblastoma subgroups. , 2015, Pathology, research and practice.
[12] L. Qin,et al. WNT5A promotes stemness characteristics in nasopharyngeal carcinoma cells leading to metastasis and tumorigenesis , 2015, Oncotarget.
[13] Baocun Sun,et al. Wnt5a Suppresses Colon Cancer by Inhibiting Cell Proliferation and Epithelial–Mesenchymal Transition , 2014, Journal of cellular physiology.
[14] D. Medici,et al. Signaling mechanisms of the epithelial-mesenchymal transition , 2014, Science Signaling.
[15] Samy Lamouille,et al. Molecular mechanisms of epithelial–mesenchymal transition , 2014, Nature Reviews Molecular Cell Biology.
[16] T. Gaasterland,et al. WNT5A Encodes Two Isoforms with Distinct Functions in Cancers , 2013, PloS one.
[17] Lei Wang,et al. Regulation of prostate cancer cell migration toward bone marrow stromal cell-conditioned medium by Wnt5a signaling. , 2013, Molecular medicine reports.
[18] S. Semba,et al. WNT5A is a Key Regulator of the Epithelial-Mesenchymal Transition and Cancer Stem Cell Properties in Human Gastric Carcinoma Cells , 2013, Pathobiology.
[19] Y. Kanda,et al. Investigation of the freely available easy-to-use software ‘EZR' for medical statistics , 2012, Bone Marrow Transplantation.
[20] Hui Jiang,et al. Loss of Wnt5a and Ror2 protein in hepatocellular carcinoma associated with poor prognosis. , 2012, World journal of gastroenterology.
[21] R. Nusse,et al. Towards an integrated view of Wnt signaling in development , 2009, Development.
[22] S. Todo,et al. Recurrence Patterns After Hepatectomy of Hepatocellular Carcinoma: Implication of Milan Criteria Utilization , 2009, Annals of Surgical Oncology.
[23] Q. Rao,et al. Expression of Wnt-5a and its clinicopathological significance in hepatocellular carcinoma. , 2008, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.
[24] Héctor Peinado,et al. Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? , 2007, Nature Reviews Cancer.
[25] T. Andersson,et al. Wnt-5a protein expression in primary dukes B colon cancers identifies a subgroup of patients with good prognosis. , 2005, Cancer research.
[26] G. Brabant,et al. Wnt-5a has tumor suppressor activity in thyroid carcinoma , 2005, Oncogene.
[27] M. Bittner,et al. Wnt5a signaling directly affects cell motility and invasion of metastatic melanoma. , 2002, Cancer cell.
[28] Li Zhu,et al. Wnt 5 a promotes epithelial-to-mesenchymal transition and metastasis in non-small cell lung cancer Short title : Wnt 5 a promotes EMT and metastasis in NSCLC , 2017 .